Quanterix Corp (NAS:QTRX)
$ 16.78 -0.44 (-2.56%) Market Cap: 642.17 Mil Enterprise Value: 397.54 Mil PE Ratio: 0 PB Ratio: 1.93 GF Score: 79/100

Quanterix Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 08:40PM GMT
Release Date Price: $67.82 (+13.81%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. We're going to kick it off. Good afternoon. I'm Tycho Peterson. It's my pleasure to introduce our next company this afternoon, Quanterix. Just a quick reminder for folks that want to ask questions to submit them through the website.

With that, let me turn it over to Kevin.

E. Kevin Hrusovsky
Quanterix Corporation - Chairman, President & CEO

Thanks, Tycho. Really excited to be presenting today. This has been a 15-year journey of hiring precision health and trying to understand how the proteomics revolution, we think, can have a very disruptive opportunity to affect and impair a lot of the diseases that are out there. And so today, I'm going to go through these agenda have vision and strategy for disruption and creating value. We're going to talk about our DIFI methodology that we've been deploying that really allows us to have a market-driven vision it's almost like we learn about the killer application. And then we go into various companies, and we evolve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot